Italy suspended the use of a flu vaccine made by Swiss pharmaceuticals giant Novartis on Thursday amid fears it may have caused three deaths.
The Italian Pharmaceutical Agency (AIFA) banned the use of two batches of the Fluad vaccine after three people who had received it died and a fourth was taken seriously ill.
The victims were two women aged 87 and 79 and a 68-year old man, all of whom died between November 12th and 19th in southern Italy, according to Italian media reports.
The fourth person, a 92-year old man, is in hospital in serious condition.
"Novartis has been notified by AIFA of the precautionary suspension of two lots of Fluad in Italy following reports of the serious adverse effects events after vaccination," the Basel-based company said. Full story...
Related posts:
The Italian Pharmaceutical Agency (AIFA) banned the use of two batches of the Fluad vaccine after three people who had received it died and a fourth was taken seriously ill.
The victims were two women aged 87 and 79 and a 68-year old man, all of whom died between November 12th and 19th in southern Italy, according to Italian media reports.
The fourth person, a 92-year old man, is in hospital in serious condition.
"Novartis has been notified by AIFA of the precautionary suspension of two lots of Fluad in Italy following reports of the serious adverse effects events after vaccination," the Basel-based company said. Full story...
Related posts:
- Japan withdraws support for HPV vaccines due to infertility side effects...
- Five seniors die in Georgia care center after receiving flu shot...
- Healthy 12-year-old girl dies shortly after receiving HPV vaccine...
- 15 Syrian children dead following UN measles vaccination campaign...
- European children suffer narcolepsy after swine-flu vaccinations...
No comments:
Post a Comment